NovoCure Ltd Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 0.00 | 53,333 | 0 | 0 | |
| Feb 26 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 88.26 | 53,333 | 4,707,171 | 188,089 | 134.8 K to 188.1 K (+39.58 %) |
| Feb 26 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 0.00 | 12,999 | 0 | 0 | |
| Feb 26 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 88.26 | 12,999 | 1,147,292 | 80,720 | 67.7 K to 80.7 K (+19.19 %) |
| Feb 26 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 43,333 | 0 | 0 | |
| Feb 26 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.16 | 18,908 | 1,534,498 | 111,768 | 130.7 K to 111.8 K (-14.47 %) |
| Feb 26 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 88.26 | 43,333 | 3,824,571 | 130,676 | 87.3 K to 130.7 K (+49.61 %) |
| Feb 26 2020 | NVCR | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Option Exercise | M | 0.00 | 21,666 | 0 | 0 | |
| Feb 26 2020 | NVCR | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Sell | S | 81.16 | 8,482 | 688,365 | 67,119 | 75.6 K to 67.1 K (-11.22 %) |
| Feb 26 2020 | NVCR | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Buy | M | 88.26 | 21,666 | 1,912,241 | 75,601 | 53.9 K to 75.6 K (+40.17 %) |
| Feb 26 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 0.00 | 31,199 | 0 | 0 | |
| Feb 26 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 81.16 | 11,647 | 945,224 | 205,226 | 216.9 K to 205.2 K (-5.37 %) |
| Feb 26 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 88.26 | 31,199 | 2,753,624 | 216,873 | 185.7 K to 216.9 K (+16.80 %) |